Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment
Yuehan Zhang(Johns Hopkins University), Gypsyamber DʼSouza(Johns Hopkins University), Harry Quon(Johns Hopkins University), Daniel Clayburgh(Oregon Health & Science University), Krzysztof Misiukiewicz(Mount Sinai Medical Center), Alicia Wentz(Johns Hopkins University), Jeremy D. Richmon(Massachusetts Eye and Ear Infirmary), Neil D. Gross(The University of Texas MD Anderson Cancer Center), Carole Fakhry(Johns Hopkins University), Christine G. Gourin(Johns Hopkins University), Robert I. Haddad(Georgetown University), Tim Waterboer(German Cancer Research Center), Brett A. Miles(Icahn School of Medicine at Mount Sinai), Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Peter E. Andersen(Oregon Health & Science University), Jochen H. Lorch(Northwestern University)
Cited by 34
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926